<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02961946</url>
  </required_header>
  <id_info>
    <org_study_id>2016P002417</org_study_id>
    <nct_id>NCT02961946</nct_id>
  </id_info>
  <brief_title>Effects of Sublingual and Transdermal Administration of Nitroglycerin for Coronary CT Angiography on Image Quality</brief_title>
  <official_title>Effects of Sublingual and Transdermal Administration of Nitroglycerin for Coronary CT Angiography on Image Quality</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate image quality of coronary CT angiography (cCTA) after sublingual and transdermal
      administration of Nitroglycerin. Aim of this prospective research study is to investigate
      equivalence on image quality after sublingual or transdermal Nitroglycerin administration
      (H0).

      Furthermore, the feasibility of transdermal Nitroglycerin administration will be evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Image quality of cCTA measured by visualization of coronary arteries (as defined by the number of visualized branch vessels).</measure>
    <time_frame>obtained on the same day (day 0) of nitroglycerine administration (nitroglycerine is administered during the cCTA exam appointment).</time_frame>
    <description>Visualization of coronary arteries including branches (ordinal scale)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Image quality of cCTA measured by coronary artery diameter.</measure>
    <time_frame>obtained on the same day (day 0) of nitroglycerine administration (nitroglycerine is administered during the cCTA exam appointment).</time_frame>
    <description>Diameter of coronary arteries.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Sublingual Nitroglycerin spray</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sublingual Nitroglycerin spray of 0.8 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sublingual Nitroglycerin tablet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sublingual Nitroglycerin tablet of 0.8 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nitroglycerin skin patch</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nitroglycerin skin patch of 0.8 mg/h</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nitroglycerin</intervention_name>
    <description>Patients grouped in sublingual administration (group 1 and 2) will receive Nitroglycerin during the cCTA scan by the MD after the Calcium scoring scan and 5 minutes before the actual cCTA scan. Patients categorized to transdermal administration will receive Nitroglycerin 1 hour before the CT examination. The patch will be placed on the chest or the upper arm.</description>
    <arm_group_label>Sublingual Nitroglycerin spray</arm_group_label>
    <arm_group_label>Sublingual Nitroglycerin tablet</arm_group_label>
    <arm_group_label>Nitroglycerin skin patch</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Scheduled cCTA with contrast.

          2. Able to comprehend and sign the consent form.

        Exclusion Criteria:

          1. Known hypersensitivity to glyceryl trinitrate, and related organic nitrates.

          2. Acute circulatory failure associated with marked hypotension (shock).

          3. Conditions associated with elevated intracranial pressure, cerebral haemorrhage and
             head trauma.

          4. Closed-angle glaucoma.

          5. Phosphodiesterase type 5 (PDE5) inhibitors such as sildenafil (ViagraÂ®), tadalafil
             (Cialis), or vardenafil (Levitra) within the last 24 hours

          6. Unstable clinical conditions (i.e. hemodynamic instability, arrhythmias)

          7. Critical aortic stenosis

          8. Systolic blood pressure &lt; 90 mmHg

          9. Pregnant or lactating female; premenopausal women with a positive urine pregnancy
             test.

         10. Age under 18

         11. Unwilling or unable to inform consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2016</study_first_submitted>
  <study_first_submitted_qc>November 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2016</study_first_posted>
  <last_update_submitted>November 9, 2016</last_update_submitted>
  <last_update_submitted_qc>November 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Brian Burns Ghoshhajra</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitroglycerin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

